Develop Novel Malaria Vaccines Against Plasmodium Vivax

To eradicate malaria, it is crucial to counter P. vivax that is more widespread than P. falciparum. Our idea is to develop novel vaccines that target P. vivax by blocking its invasion of human red cells and reduce disease burden.

Grant ID
ST-POC-0163-01
Show on Hub
On
Show on Spoke
Off
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
56500.00
Funding Currency
CAD
Exchange Rate (at time of payment)
0.7500000000
Funding Amount (in USD)
42375.00
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
42375.00
Co-Funded
False